Top Markets
#1 MowCat MowCat +48.96%
#2 Bermuda Shorts Bermuda Shorts +24.00%
#3 Velvet Velvet +22.97%
#4 Fake World Assets Fake World Assets +21.43%
#5 Quack AI Quack AI +19.20%
#6 Perle Perle +18.21%
#7 Block Street Block Street +17.95%
#8 Derive Derive +15.58%
#9 龙虾 (Lobster) 龙虾 (Lobster) +12.63%
#10 DUSK Network DUSK Network +12.02%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
GeneTether Therapeutics Inc. GeneTether Therapeutics Inc.

GeneTether Therapeutics Inc.

GTTX
Rank in Stocks #34710
GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in... GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in genetic medicines. Its primary focus is the advancement of gene-editing therapies, aiming to significantly boost the effectiveness of current genomic modification techniques. The company's pipeline is dedicated to engineering genetic treatments for individuals suffering from rare, single-gene disorders affecting the kidneys and skin. Established in 2018, GeneTether Therapeutics Inc. is headquartered in Kelowna, Canada.
Share Price
$0.10409799
Last synced: 2025-02-03
Market Cap
$5.07M
Change (1 day)
16.43%
Change (1 year)
0.00%
Country
CA
Trade GeneTether Therapeutics Inc. (GTTX)

Category

Healthcare
Revenue for GeneTether Therapeutics Inc. (GTTX)
Revenue in Aug 2026 TTM: 0
According to GeneTether Therapeutics Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for GeneTether Therapeutics Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE